US loss of exclusivity · Immunology
Otezla
Amgen
2028
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$2.3B
Date basis
Settlement / court date
US generics
Approved, waiting to launch
Medicare price
−65% from 2027
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Otezla timeline →